Gefinorm
-
Gefinorm
Gefitinib
250mg
Film Coated Tablet
Indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
×Gefinorm
Generic Name:Gefitinib
Available In:250mg
Dosage Form:Film Coated Tablet
Indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
Reminder: Food, Drugs, Devices, and Cosmetics Act prohibits dispensing w/o prescription.
-
